Iria Bastón‐Rey

Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study

Manuel Barreiro‐de Acosta, Nicolau Vallejo, Daniel de la Iglesia et al. · Journal of Crohn s and Colitis · 2015 · 216 citations · Full text

Medicine, Immunology, Gastroenterology +11

Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy

Uri Kopylov, Jurij Hanžel, Claire Liefferinckx et al. · Alimentary Pharmacology & Therapeutics · 2020 · 80 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +5

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

María Chaparro, Iria Bastón‐Rey, E Fernández-Salgado et al. · Inflammatory Bowel Diseases · 2022 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

High primary antibiotic resistance of <i>Helicobacter Pylori</i> strains isolated from dyspeptic patients: A prevalence cross‐sectional study in Spain

Fernando Macías‐García, José Llovo‐Taboada, Mario Díaz‐López et al. · Helicobacter · 2017 · 47 citations

Life Sciences, Infectious Diseases, Microbiology +16

Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease

Iago Rodríguez–Lago, Javier del Hoyo, Alexandre Pérez‐Girbés et al. · United European Gastroenterology Journal · 2020 · 47 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12